Cannabis ETF

Two cannabis-based ETF leaders discussed why U.S. investors turn to ETFs for sector exposure and what federal regulation could mean for the industry during a panel at the 2025 Benzinga Cannabis Capital Conference in Chicago. ETF Convenience: AdvisorShares Chief Operating Officer Dan Ahrens...

Amplify ETFs announced Wednesday that it plans to liquidate the Amplify U.S. Alternative Harvest ETF (NYSE:MJUS), with trading set to end Jan. 27. The Amplify U.S. Alternative Harvest ETF has a significant allocation to cannabis-related companies like Green Thumb Industries (OTC:GTBIF) and Curaleaf...

AdvisorShares has announced a reverse split for its MSOS Daily Leveraged ETF (NYSE:MSOX), effective November 26, 2024. A reverse split reduces the number of its outstanding shares, increasing the share price proportionally. In this case, the split will be 1-for-20, with every 20 shares of MSOX...

Following Donald Trump's presidential election victory Tuesday, the cannabis sector took a sharp downturn. Here's a summary of the largest stock declines across the industry based on data from Benzinga Pro. Get Benzinga’s exclusive analysis and the top news about the cannabis industry and...

The cannabis sector has seen its share of turbulence, highlighted by a 15.24% drop in the MSOS ETF (NYSE:MSOS) following the DEA’s decision to delay the rescheduling of cannabis until December 2nd. This delay adds to the uncertainty in an already volatile market, particularly as the U.S....

Roundhill Investments has announced a fee waiver for its Listed Funds Trust Roundhill Cannabis ETF (BATS:WEED). The ETF, which provides exposure to leading U.S. cannabis multi-state operators, will charge an all-in expense ratio of 0% until at least July 1, 2025. WEED ETF Cuts Fees Amid Looming...

In a recent issue of "Cannabis Confidential," Todd Harrison provides a succinct analysis of the current market dynamics within the cannabis industry, particularly highlighting the performance of AdvisorShares Pure US Cannabis ETF (NYSE: MSOS). Harrison, known for his expertise in...

Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is a key voice in the cannabis investment community. With an insightful understanding of market dynamics, Seymour recently shared his views with Benzinga Cannabis on what truly drives growth in the...

Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is renowned for recognizing the potential of the cannabis sector early on. In an exclusive interview with Benzinga Cannabis, he discussed the critical role of strategic partnerships in expanding market reach...

Cannabis stocks experienced a notable surge last week following the U.S. Department of Justice’s announcement to propose the reclassification of cannabis from a Schedule I to a Schedule III drug. This decision, long anticipated by market analysts and industry stakeholders, has been described...

In the latest report from Water Tower Research (WTR) published Monday, seasoned industry analyst Jesse Redmond provides a comprehensive overview of the most recent investment trends and legal shifts in the cannabis sector.  Redmond’s analysis will doubtless trigger conversation at the...

Cannabis ETFs are experiencing one of their most dynamic years yet, driven by significant regulatory shifts. The Department of Health and Human Services‘ recommendation to reclassify cannabis from a Schedule I to a Schedule III drug under the Controlled Substances Act marks a pivotal moment....

Subversive Capital Advisor is set to launch its sixth exchange-traded fund (ETF) named Subversive Cannabis ETF (BATS: LGLZ) on the Cboe BZX Exchange, which is operated by Cboe Global Markets, a key global venue for listing exchange-traded products. Targeting long-term capital appreciation...

"Early days hype-driven capital was wasted. It was not well allocated," Emily Paxhia, the founding and managing partner of Poseidon Investment Management said at the recent Benzinga Cannabis Capital Conference in Miami. If you missed her in Miami, you'll be glad to know that...

The death of U.S. federal cannabis reform isn't just hitting industry retail and cultivation operators. Sliding equity values have also taken down AdvisorShares Poseidon Dynamic Cannabis ETF (NYSE: PSDN), a Fund run by the affable Emily & Morgan Paxhia. According to a banner posted on the...